Guggenheim Initiates Coverage On Praxis Precision Medicine With Buy Rating, Announces Price Target of $155
Guggenheim Initiates Coverage On Praxis Precision Medicine With Buy Rating, Announces Price Target of $155
Guggenheim發佈買入評級，給Praxis Precision Medicine設定了$155的塔吉特價格。
Guggenheim analyst Yatin Suneja initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX) with a Buy rating and announces Price Target of $155.
Guggenheim分析師Yatin Suneja開始對Praxis Precision Medicine（NASDAQ：PRAX）進行覆蓋，並給出買入評級並公佈了155美元的目標股價。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。